background
influenza
virus
fluv
continu
evolv
explain
occurr
season
influenza
epidem
need
review
vaccin
strain
composit
annual
aim
describ
genet
divers
clinic
outcom
fluv
detect
tertiari
univers
hospit
barcelona
spain
season
method
detect
fluv
patient
attend
emerg
depart
admit
hospit
perform
either
immunofluoresc
pcrbase
assay
specif
realtim
onestep
multiplex
rtpcr
perform
influenza
fluav
subtyp
complet
code
haemagglutinin
domain
neuraminidas
na
protein
sequenc
repres
sampl
molecular
characteris
result
total
fluav
influenza
b
flubv
case
laboratoryconfirm
hospitalis
rate
differ
season
highest
season
fluv
genet
close
vaccin
strain
except
characteris
virus
belong
genet
group
differ
vaccin
strain
season
bvictorialik
virus
predomin
compon
includ
trival
vaccin
use
mutat
found
strain
icuadmit
case
three
strain
carri
na
mutat
respect
relat
resist
decreas
suscept
oseltamivir
conclus
circul
drift
strain
season
relat
high
hospitalis
rate
due
mismatch
vaccin
strain
predomin
flubv
lineag
includ
trival
influenza
vaccin
season
highlight
need
use
tetraval
influenza
vaccin
virolog
surveil
viral
variant
carri
protein
chang
alter
tropism
suscept
antivir
featur
strengthen
hospit
set
elsevi
ltd
right
reserv
influenza
virus
fluv
one
main
caus
agent
respiratori
infect
relat
high
morbid
mortal
commun
mainli
highrisk
patient
elderli
underli
comorbid
pregnant
women
fluv
singlestrand
negativesens
segment
rna
virus
belong
orthomyxovirida
famili
base
genet
antigen
featur
three
differ
type
human
fluv
b
c
current
describ
accord
antigen
properti
surfac
protein
haemagglutinin
ha
neuraminidas
na
influenza
virus
fluav
divid
differ
subtyp
well
influenza
b
virus
flubv
two
major
lineag
flubvvic
flubvyam
fluv
continu
evolv
amino
acid
substitut
alter
antigen
properti
antigen
drift
less
frequent
segment
reassort
event
antigen
shift
amino
acid
substitut
ha
receptor
bind
site
rb
alter
cellular
host
tropism
condit
speci
rang
tissu
tropism
may
also
relat
viral
virul
high
mutat
rate
na
protein
also
affect
antivir
suscept
current
avail
neuraminidas
inhibitor
nai
drug
addit
chang
antigen
featur
fluav
flubv
mainli
ha
explain
occurr
season
influenza
epidem
reason
annual
vaccin
composit
updat
need
effect
prevent
diseas
relat
complic
highrisk
patient
vaccin
effect
public
health
action
prevent
influenza
higher
vaccin
enhanc
achiev
commun
immunis
catalonia
influenza
vaccin
recommend
individu
year
age
especi
live
nurs
home
children
month
age
adult
high
risk
comorbid
clinic
complic
due
influenza
infect
pregnanc
chronic
diseas
also
recommend
healthcar
profession
peopl
work
public
servic
polic
firefight
teacher
influenza
vaccin
avail
catalonia
subunit
adjuv
cellbas
vaccin
tetraval
vaccin
avail
sinc
season
vaccin
highrisk
patient
hospit
set
vaccin
coverag
region
variabl
goe
depend
age
group
although
mean
coverag
around
season
aim
studi
describ
genet
featur
detect
virus
clinic
outcom
influenza
case
attend
vall
dhebron
univers
hospit
barcelona
spain
season
vall
dhebron
univers
hospit
largest
tertiari
hospit
catalonia
second
one
spain
cover
inhabit
octob
epidemiolog
week
may
epidemiolog
week
upper
nasopharyng
aspir
swab
lower
bronchoalveolar
lavag
bronchoaspir
tracheal
aspir
respiratori
tract
specimen
collect
influenza
respiratori
virus
laboratoryconfirm
patient
suspicion
acut
respiratori
tract
infect
attend
emerg
depart
accomplish
criteria
admit
hospit
patient
could
benefit
antivir
treatment
without
need
hospitalis
hospitalis
patient
acquir
influenza
nosocomi
infect
base
medic
record
demograph
featur
age
sex
hospitalis
intens
care
unit
icu
admiss
outcom
administr
antivir
treatment
retrospect
collect
influenza
laboratoryconfirm
case
accord
catalan
public
health
agenc
sever
hospitalis
patient
describ
case
pneumonia
due
influenza
viru
bacteri
infect
septic
shock
multiorgan
failur
acut
respiratori
distress
admiss
intens
care
unit
icu
moreov
antivir
nai
treatment
administ
influenza
infect
laboratoryconfirm
patient
hospitalis
due
sever
diseas
belong
highrisk
group
prevent
diseas
complic
detect
fluv
respiratori
virus
respiratori
syncyti
viru
metapneumoviru
adenoviru
rhinovirus
enterovirus
coronavirus
parainfluenza
virus
bocaviru
carri
either
immunofluoresc
antigen
detect
sofia
influenza
b
quidel
california
usa
ultra
dfa
respiratori
viru
screen
identif
kit
diagnost
hybrid
usa
pcrbase
assay
anyplex
ii
detect
kit
seegen
korea
genexpert
flu
cepheid
usa
prior
pcrbase
assay
total
nucleic
acid
extract
use
nuclisen
easymag
marci
letoil
franc
accord
manufactur
instruct
kept
frozen
use
inhous
realtim
onestep
multiplex
rtpcr
perform
ha
subtyp
season
influenza
virus
complet
code
region
repres
number
influenza
laboratoryconfirm
specimen
hospitalis
patient
sequenc
phylogenet
analysi
molecular
characteris
addit
season
complet
na
code
region
also
sequenc
screen
amino
acid
substitut
associ
reduc
antivir
suscept
ha
na
amplif
carri
onestep
rtpcr
assay
use
onestep
rtpcr
kit
qiagen
hilden
germani
primer
pcr
protocol
shown
supplementari
tabl
pcr
product
purif
subsequ
perform
use
exosapit
usb
affymetrix
inc
cleveland
ohio
usa
sequenc
abi
prism
big
dye
termin
cycl
sequenc
kit
thermo
fisher
scientif
waltham
usa
abi
prism
genet
analyz
thermo
fisher
scientif
waltham
usa
sequenc
primer
supplementari
tabl
nucleotid
sequenc
edit
assembl
use
seqscap
softwar
thermo
fisher
scientif
waltham
usa
sequenc
present
studi
submit
global
initi
share
avian
influenza
data
gisaid
avail
wwwplatformgisaidorg
phylogenet
analys
complet
code
region
sequenc
perform
use
refer
sequenc
subtyp
fluav
lineag
flubv
season
northern
hemispher
recommend
european
centr
diseas
prevent
control
ecdc
supplementari
tabl
multipl
nucleotid
sequenc
align
use
muscl
algorithm
molecular
evolutionari
model
analysi
conduct
mega
phylogenet
tree
construct
use
neighborjoin
nj
distanc
method
implement
mega
nucleotid
substitut
model
lowest
bayesian
inform
criterion
bic
score
topolog
accuraci
intern
branch
evalu
bootstrap
method
replic
order
detect
amino
acid
substitut
complet
na
code
region
deduc
amino
acid
sequenc
align
nucleotid
sequenc
compar
vaccin
strain
recommend
world
health
statist
analysi
perform
use
stata
statacorp
stata
statist
softwar
releas
colleg
station
tx
statacorp
lp
descript
analysi
perform
calcul
median
measur
central
tendenc
well
interquartil
rang
measur
dispers
categor
variabl
describ
frequenc
proport
chisquar
test
calcul
assess
associ
categor
variabl
p
valu
consid
statist
signific
total
specimen
case
median
age
year
femal
receiv
respiratori
virus
laboratoryconfirm
specimen
patient
median
age
year
femal
laboratoryconfirm
fluav
femal
flubv
femal
fluv
detect
usual
report
winter
month
sporad
case
detect
interseason
period
fig
addit
detect
fluv
steadili
increas
studi
period
p
variabl
cocircul
differ
influenza
type
shown
sinc
fluav
circul
season
flubv
circul
season
moreov
particular
influenza
type
subtyp
also
predomin
stud
data
regard
demograph
featur
age
sex
hospitalis
rate
icuadmiss
antivir
treatment
administr
fatal
outcom
influenzaconfirm
case
season
summaris
tabl
overal
median
age
fluavconfirm
case
year
iqr
year
significantli
higher
p
flubvconfirm
case
year
iqr
year
howev
signific
differ
p
year
iqr
year
year
iqr
year
found
though
differ
distribut
age
group
found
influenza
type
p
subtyp
p
hospitalis
rate
influenza
laboratoryconfirm
case
overal
case
balanc
male
femal
proport
femal
p
furthermor
hospitalis
rate
differ
season
p
highest
season
hospitalis
rate
also
significantli
differ
influenza
type
fluav
vs
flubv
p
fluav
subtyp
vs
p
among
hospitalis
patient
icuadmiss
also
differ
season
throughout
studi
period
show
decreas
trend
p
differ
icu
admiss
influenza
type
fluav
vs
flubv
p
observ
differ
fluav
subtyp
vs
p
studi
period
also
decreas
trend
mortal
p
differ
observ
influenza
type
p
fluav
subtyp
p
nevertheless
high
number
fatal
case
attribut
season
remark
comparison
later
season
phylogenet
analys
sequenc
reveal
high
genet
divers
fluv
distinguish
differ
genet
clade
subclad
repres
fig
ad
supplementari
tabl
regard
virus
sequenc
cluster
clade
season
follow
season
sequenc
fell
two
subgroup
within
clade
fig
strain
gain
new
glycosyl
site
addit
sequenc
characteris
amino
acid
sequenc
code
sequenc
also
reveal
detect
viral
variant
carri
follow
amino
acid
substitut
rb
case
case
case
among
virus
case
among
flubv
found
sampl
upper
respiratori
tract
addit
case
case
mutat
virus
season
later
detect
upper
case
lower
case
respiratori
specimen
three
icuadmit
patient
one
fatal
outcom
mutat
rb
associ
sever
diseas
previou
studi
regard
amino
acid
substitut
associ
reduc
nai
suscept
two
mutat
found
three
virus
case
case
respiratori
sampl
collect
immunosuppress
patient
favour
respond
standard
fiveday
oseltamivir
treatment
sampl
two
case
collect
treatment
one
one
day
onset
start
treatment
present
studi
preval
genet
divers
clinic
outcom
detect
fluv
patient
attend
hospitalis
tertiari
hospit
catalonia
report
might
consid
continu
influenza
surveil
report
catalonia
previous
publish
shown
fig
number
fluv
detect
case
per
season
increas
season
might
relat
improv
detect
method
broader
use
pcrbase
method
rather
antigendetect
base
assay
laboratori
well
strengthen
surveil
respiratori
virus
hospit
cocircul
fluav
flubv
four
consecut
season
highli
variabl
shift
predomin
influenza
type
subtyp
overal
circul
fluv
show
similar
proport
report
spanish
region
show
differ
comparison
european
countri
previou
studi
alreadi
report
differ
catalonia
spanish
region
fluav
predomin
three
four
studi
season
except
season
flubv
frequent
detect
similarli
spanish
region
differ
european
countri
subtyp
level
season
predominantli
detect
catalonia
base
result
also
data
provid
public
health
agenc
contrast
spanish
commun
european
countri
heterogen
variabl
tempor
geograph
level
fluv
circul
reinforc
idea
maintain
local
continu
influenza
surveil
clinic
impact
influenza
epidem
commun
alway
consid
valuabl
data
review
take
account
fluv
genet
divers
therefor
differ
found
influenza
type
vs
b
subtyp
vs
vice
versa
regard
age
clinic
outcom
influenzaconfirm
case
hospitalis
icuadmiss
mortal
rate
present
studi
popul
suscept
fluav
infect
seem
older
suscept
flubv
although
fluav
predomin
almost
age
group
except
group
flubv
prevail
previous
report
author
hand
differ
found
distribut
case
age
group
differ
hospitalis
rate
variabl
throughout
studi
report
differ
season
might
relat
predomin
influenza
type
subtyp
overal
fluav
relat
higher
hospitalis
rate
tabl
detect
age
median
age
categoriesgroup
femal
hospitalis
icuadmiss
antivir
treatment
mortal
rate
n
influenza
type
subtyp
season
column
depend
influenza
typesubtyp
flubv
respect
howev
associ
higher
hospitalis
lower
icuadmiss
rate
might
explain
due
high
number
hospitalis
case
season
drift
viru
circul
mortal
rate
declin
along
studi
period
show
differ
fluv
type
subtyp
highlight
high
mortal
rate
season
low
number
fluav
case
report
decreas
mortal
rate
four
season
could
relat
increas
frequenc
sampl
due
introduct
pcrbase
method
speed
diagnost
treatment
reduc
complic
base
phylogenet
analysi
sequenc
show
higher
heterogen
despit
emerg
spread
genet
diverg
strain
differ
genet
subgroup
within
clade
report
worldwid
current
virus
remain
antigen
similar
vaccin
strain
sinc
begin
pandem
howev
despit
antigen
stabil
still
caus
sever
hospitalis
hand
viru
shown
great
capabl
evolv
quickli
due
mayb
immun
pressur
human
popul
infect
global
circul
year
last
season
virus
acquir
great
number
amino
acid
substitut
diverg
differ
genet
clade
subclad
shown
present
studi
continu
chang
potenti
glycosyl
featur
ha
fact
previous
comment
high
activ
virus
season
relat
circul
virus
antigen
differ
vaccin
strain
use
howev
unpredict
evolut
fluv
togeth
current
challeng
correct
antigen
characteris
virus
make
difficult
forecast
vaccin
composit
upcom
season
regard
flubv
cocircul
lineag
predomin
flubvyam
two
three
season
flubv
detect
report
well
correspond
strain
lineag
includ
trival
vaccin
composit
shift
predomin
lineag
wellknown
sometim
circul
lineag
includ
trival
vaccin
highlight
need
use
tetraval
influenza
vaccin
give
better
wider
protect
highrisk
popul
therefor
vaccin
tetraval
vaccin
primari
care
would
improv
attitud
toward
influenza
vaccin
benefici
effect
popul
coverag
addit
circul
flubv
lineag
flubv
also
show
continu
evolut
base
ha
sequenc
therefor
flubvyam
virus
belong
two
genet
antigen
diverg
genet
clade
clade
one
clade
repres
correspond
vaccin
strain
season
regard
detect
virul
resist
marker
capabl
acquir
mutat
alter
tropism
antivir
suscept
infect
one
hand
strain
icuadmit
case
carri
mutat
still
uniqu
genet
marker
relat
diseas
sever
detect
season
later
season
higher
mortal
rate
report
sure
preval
variant
carri
mutat
might
underestim
due
suboptim
characteris
sever
influenza
case
sinc
virolog
surveil
influenza
virus
overal
carri
sampl
collect
communitybas
surveil
network
hand
emerg
genet
resist
variant
antivir
drug
one
main
concern
influenza
surveil
public
health
worldwid
present
studi
three
virus
carri
mutat
associ
resist
reduc
suscept
nai
found
respiratori
specimen
hospitalis
patient
standard
oseltamivir
treatment
season
fact
immunosuppress
statu
antivir
treatment
administr
consid
highrisk
factor
select
emerg
resist
strain
condit
accomplish
mani
patient
hospitalis
tertiari
centr
highlight
import
strengthen
virolog
surveil
influenza
virus
hospit
set
surveil
task
communitybas
network
highli
valuabl
inform
report
hospit
set
case
sever
diseas
antivir
resist
attend
alway
consid
monitor
circul
virus
particular
novel
phenotyp
featur
summari
result
highlight
preval
fluv
patient
admit
tertiari
hospit
variabl
unpredict
circul
capabl
fluv
acquir
genet
divers
affect
viral
featur
relat
antigen
trop
ism
suscept
antivir
make
virolog
surveil
variant
monitor
highli
recommend
hospit
set
institut
review
board
approv
pr
ag
obtain
vall
dhebron
univers
hospit
huvh
clinic
research
ethic
committe
